Skip to content

Catalent to make active ingredient for AstraZeneca’s COVID-19 vaccine candidate

August 24, 2020

Catalent Inc said on Monday it will manufacture active ingredient for AstraZeneca Plc and the University of Oxford’s COVID-19 vaccine candidate.

It will be made at Catalent’s commercial gene therapy manufacturing facility located in Harmans, Maryland, the company said.

https://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-Catalent-to-make-active-ingredient-for-AstraZeneca-s-COVID-19-vaccine-candidate-31166267/

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: